Диссертация (1144820), страница 59
Текст из файла (страница 59)
Genetic variants in novel pathways influence blood pressure andcardiovascular disease risk // Nature. – 2011. – V. 478, № 7367. – P. 103–109.218.Ishibashi O., Ohkuchi A., Ali M.M., Kurashina R., Luo S.S., Ishikawa T.,Takizawa T., Hirashima C., Takahashi K., Migita M., Ishikawa G., Yoneyama K.,Asakura H., Izumi A., Matsubara S., Takeshita T., Takizawa T.
Hydroxysteroid(17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that areaberrantlyexpressedinpreeclampticplacentas:anovelmarkerforpredicting preeclampsia // Hypertension. – 2012. – V. 59(2). – P. 265–273.219.Jaccard P. The distribution of the flora in the alpine zone // Newphytologist. – 1912.
– V. 11, № 2 – P. 37–50.220.Jenssen T.K., Laegreid A., Komorowski J., Hovig E. A literature networkof human genes for high-throughput analysis of gene expression // Nat. Genet. –2001. – V. 28. – P. 21–28.221.Jiang Q., Wang Y., Hao Y., Juan L., Teng M., Zhang X., Li M., Wang G.,Liu Y. miR2Disease: a manually curated database for microRNA deregulation inhuman disease // Nucleic Acids Res. – 2009.
– V. 37. – P. D98–104386387222.Jin J.J., Nakura J., Wu Z., Yamamoto M., Abe M., Chen Y., Tabara Y.,Yamamoto Y., Igase M., Bo X., Kohara K., Miki T. Association of angiotensin IItype 2 receptor gene variant with hypertension // Hypertens. Res. – 2003. – V. 26,№ 7. – P. 547–552.223.John B., Enright A.J., Aravin A., Tuschl T., Sander C., Marks D.S. HumanMicroRNA targets // PLoS Biol. – 2004.
– V. 2, № 11. – P. 1862–1879.224.Johnson A.D., Newton-Cheh C., Chasman D.I., Ehret G.B., Johnson T.,Rose L., Rice K., Verwoert G.C., Launer L.J., Gudnason V., Larson M.G.,Chakravarti A., Psaty B.M.,Caulfield M., van Duijn C.M., Ridker P.M., MunroeP.B, Levy D.; Cohorts for Heart and Aging Research in Genomic EpidemiologyConsortium; Global BPgen Consortium; Women's Genome Health Study.Association of hypertension drug target genes with blood pressure andhypertension in 86,588 individuals // Hypertension. – 2011. V. 57(5).
– P. 903–910.225.Johnson A.D., Newton-Cheh C., Chasman D.I., Ehret G.B., JohnsonT., RoseL., RiceK., VerwoertG.C., LaunerL.J., GudnasonV., LarsonM.G., Chakravarti A., Psaty B.M., Caulfield M., van Duijn C.M., RidkerP.M., Munroe P.B., Levy D. Cohorts for Heart and Aging Research in GenomicEpidemiology Consortium; Global BPgen Consortium; Women's Genome HealthStudy.Associationof hypertension drugtarget genes withbloodpressureand hypertension in 86,588 individuals // Hypertension. – 2011. V. 57, № 5. – P.903–910.226.Johnson M.P., Brennecke S.P., East C.E., Göring H.H., Kent J.W. Jr., DyerT.D., Said J.M., Roten L.T., Iversen A.C., Abraham L.J., Heinonen S., KajantieE., Kere J., Kivinen K., Pouta A., Laivuori H.; FINNPEC Study Group, AustgulenR., Blangero J., Moses E.K.
Genome-wide association scan identifies a risk locusfor preeclampsia on 2q14, near the inhibin, beta B gene // PLoS One. – 2012. –V.7, № 3. P. e33666.227.Johnson T., Gaunt T.R., Newhouse S.J., Padmanabhan S., TomaszewskiM., Kumari M., Morris R.W., Tzoulaki I., O'Brien E.T., Poulter N.R., Sever P.,387388Shields D.C., Thom S., Wannamethee S.G., Whincup P.H., Brown M.J., ConnellJ.M., Dobson R.J., Howard P.J., Mein C.A., Onipinla A., Shaw-Hawkins S., ZhangY., Davey Smith G., Day I.N., Lawlor D.A., Goodall A.H.; CardiogenicsConsortium, Fowkes F.G., Abecasis G.R., Elliott P., Gateva V.; Global BPgenConsortium, Braund P.S., Burton P.R., Nelson C.P., Tobin M.D., van der Harst P.,Glorioso N., Neuvrith H., Salvi E., Staessen J.A., Stucchi A., Devos N.,Jeunemaitre X., Plouin P.F., Tichet J., Juhanson P., Org E., Putku M., Sõber S.,Veldre G., Viigimaa M., Levinsson A., Rosengren A., Thelle D.S., Hastie C.E.,Hedner T., Lee W.K., Melander O., Wahlstrand B., Hardy R., Wong A., CooperJ.A., Palmen J., Chen L., Stewart A.F., Wells G.A., Westra H.J., Wolfs M.G.,Clarke R., Franzosi M.G., Goel A., Hamsten A., Lathrop M., Peden J.F., SeedorfU., Watkins H., Ouwehand W.H., Sambrook J., Stephens J., Casas J.P., Drenos F.,Holmes M.V., Kivimaki M., Shah S., Shah T., Talmud P.J., Whittaker J., WallaceC., Delles C., Laan M., Kuh D., Humphries S.E., Nyberg F., Cusi D., Roberts R.,Newton-Cheh C., Franke L., Stanton A.V., Dominiczak A.F., Farrall M.,Hingorani A.D., Samani N.J., Caulfield M.J., Munroe P.B.
Blood pressure lociidentified with a gene-centric array // Am. J. Hum. Genet. – 2011. – V. 89, № 6. –P. 688–700.228.Jones A., Dhamrait S.S., Payne J.R., Hawe E., Li P., Toor I.S., Luong L.,Wootton P.T., Miller G.J., Humphries S.E., Montgomery H.E. Genetic variants ofangiotensin II receptors and cardiovascular risk in hypertension // Hypertension. –2003. – V. 42(4).
– P. 500–506.229.Jones A., Woods D.R. Skeletal muscle RAS and exercise performance //Int. J. Biochem. Cell. Biol. – 2003. – V. 35(6). – P. 855–866.230.Kanaeva M.D., Glotov A.S., Vashukova E.S., Obraztsova G.E., and B. S.Baranov Study of Genetic Susceptibility to the Development of ArterialHypertension in Children in Northwestern Russia // Russian Journal of Genetics:Applied Research. – 2014. – V. 4, №5. – P. 382–387.231.Kanungo T., Mount D.M., Netanyahu N.S., Piatko C.D., Silverman R., WuA.Y.
An efficient k-means clustering algorithm: Analysis and implementation //388389IEEE Trans. Pattern Analysis and Machine Intelligence. – 2009. – V. 24, № 7. – P.881–892.232.Kathiresan S., Voight B. F., Purcell S. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copynumber variants // Nat. Genet. – 2009.
– V. 41. – P. 334–341.233.Kikuya M., Sugimoto K., Katsuya T., Suzuki M., Sato T., Funahashi J.,Katoh R., Kazama I., Michimata M., Araki T., Hozawa A., Tsuji I., Ogihara T.,Yanagisawa T., Imai Y., Matsubara M. A/C1166 gene polymorphism of theangiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the OhasamaStudy // Hypertens. Res. – 2003. – V. 26(2). – P. 141–145.234.Kim Y.J., Williamson R.A., Chen K., Smith J.L., Murray J.C., MerrillD.C. Lipoprotein lipase gene mutations and the genetic susceptibility ofpreeclampsia // Hypertension.
– 2001. – V. 38. – P. 992–996.235.Kitsios G.D., Zintzaras E. Genomic convergence of genome-wideinvestigations for complex traits // Ann. Hum. Genet. – 2009. – V. 73, №5. – P.514–519.236.Knierim E., Lucke B., Schwarz J.M., Schuelke M., Seelow D. Systematiccomparison of three methods for fragmentation of long-range PCR products fornext generation sequencing // PLoS One. – 2011. – V.
6, № 11. – P. e28240.237.Koivukoski L., Fisher S.A., Kanninen T., Lewis C.M., von Wowern F.,Hunt S., Kardia S.L., Levy D., Perola M., Rankinen T., Rao D.C., Rice T., ThielB.A., Melander O. Meta-analysis of genome-wide scans for hypertension andblood pressure in Caucasians shows evidence of susceptibility regions onchromosomes 2 and 3 // Hum.
Mol. Genet. – 2004. – V. 13, № 19. – P. 2325–2332.238.Kolchinsky A., Mirzabekov A. Analysis of SNPs and other genomicvariations using gel-based chips // Hum. Mutat. – 2002. – V. 19, № 4. – P. 343–360.239.Kotlabova K., Doucha J., Hromadnikova I.
Placental-specific microRNAin maternal circulation--identification of appropriate pregnancy-associated389390microRNAs with diagnostic potential // J. Reprod. Immunol. – 2011. – V. 89, № 2.– P. 185–191.240.Kozomara A., Griffiths-Jones S. miRBase: integrating microRNAannotation and deep-sequencing data // Nucleic Acids Res. – V. 39. – DatabaseIssue. – P. D152–157.241.Krajinovic M., Labuda D., Mathonnet G., Labuda M., Moghrabi A.,Champagne J., Sinnett D.
Polymorphisms in genes encoding drugs and xenobioticmetabolizing enzymes, DNA repair enzymes, and response to treatment ofchildhood acute lymphoblastic leukemia // Clin. Cancer. Res. – 2002. – V. 8. – P.802–810.242.Kujovich JL. Thrombophilia and pregnancy complications // Am. J.Obstet. Gynecol. – 2004. – V. 191. – P.
412–424.243.Kumar P., Henikoff S., Ng P.C. Predicting the effects of codingnonsynonymous variants on protein function using the SIFT algorithm // NatureProtocols. – 2009. – V. 4. – P. 1073–1081.244.Kupferminc M.J. Thrombophilia and preeclampsia: the evidence so far //Clin. Obstet. Gynecol. – 2005. – V. 48. – P. 406–415.245.Kupferminc M.J.
Thrombophilia and pregnancy // Curr. Pharm. Des. –2005. – V. 11, № 6. – P. 735–748.246.Kurland L., Liljedahl U., Karlsson J., Kahan T., Malmqvist K., Melhus H.,Syvanen A.C., Lind L. Angiotensinogen gene polymorphisms: relationship toblood pressure response to antihypertensive treatment. Results from the SwedishIrbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial// Am.
J. Hypertens. – 2004. – V. 17(1). – P. 8–13.247.Kurokawa N., Young E.H., Oka Y., Satoh H., Wareham N.J., SandhuM.S., Loos R.J. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44833 individuals // Int. J. Obes. (Lond). – 2008. – V. 32(8). – P. 1240–1249.248.Lachmeijer A.M., Nosti-Escanilla M.P., Bastiaans E.B., Pals G., SandkuijlL.A., Kostense P.J., Aarnoudse J.G., Crusius J.B., Peña A.S., Dekker G.A.,Arngrímsson R., ten Kate L.P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
